Press Releases

Powder containment and sterile transfer solutions provider, ChargePoint Technology has achieved HazLoc (Hazardous Area) certification for VERIFI to further support customers in North America. The HazLoc certification has been granted by the Canadian Standards Association (CSA)...

CRISPR Therapeutics , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and ProBioGen. A premier German service and technology provider, announced a multi-year research collaboration focused on the development of novel in...

The US FDA has granted approval for Samsung Bioepis to use Ontruzant (trastuzumab-dttb) to treat a range of cancers. Ontruzant, which will be marketed in the US by Merck, is a biosimilar to Roche’s Herceptin. It...

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry announced the launch of the BIOSTAT® RM TX single-use bioreactor, a new wave mixed system developed specifically for closed, automated expansion of consistent quality cell products such...

Quanticate, a leading global data-focused clinical research organisation (CRO) has launched QVigilance to provide dedicated pharmacovigilance (PV) and risk management services. QVigilance will be focused on supporting small and mid-size companies transitioning from clinical trials to...

Eisai Co., Ltd. and Purdue Pharma L.P. announced that a new drug application has been submitted to the U.S. FDA for lemborexant, an investigational agent for sleep-wake regulation, seeking approval for the treatment of insomnia, a sleep-wake disorder. ...

As the pharmaceutical industry has changed and grown in the last two decades, there are increasing concerns about the safe handling of active pharmaceutical ingredients (APIs)– particularly in the process of removing catalysts from API slurries which has a...